Norway · Delayed Price · Currency is NOK Lytix Biopharma ASA Statistics
Total Valuation
OSL:LYTIX has a market cap or net worth of NOK 761.31 million. The enterprise value is 643.15 million.
| Market Cap | 761.31M |
| Enterprise Value | 643.15M |
Important Dates
The last earnings date was Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:LYTIX has 76.90 million shares outstanding.
| Current Share Class | 76.90M |
| Shares Outstanding | 76.90M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.51% |
| Owned by Institutions (%) | 14.76% |
| Float | 38.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.65 |
| P/TBV Ratio | 6.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.81 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.50, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.50 |
| Quick Ratio | 9.50 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -366.78 |
Financial Efficiency
Return on equity (ROE) is -69.65% and return on invested capital (ROIC) is -45.09%.
| Return on Equity (ROE) | -69.65% |
| Return on Assets (ROA) | -37.37% |
| Return on Invested Capital (ROIC) | -45.09% |
| Return on Capital Employed (ROCE) | -67.04% |
| Weighted Average Cost of Capital (WACC) | 1.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.21M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.73% in the last 52 weeks. The beta is -0.50, so OSL:LYTIX's price volatility has been lower than the market average.
| Beta (5Y) | -0.50 |
| 52-Week Price Change | +20.73% |
| 50-Day Moving Average | 10.39 |
| 200-Day Moving Average | 9.36 |
| Relative Strength Index (RSI) | 42.75 |
| Average Volume (20 Days) | 49,141 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -77.39M |
| Pretax Income | -73.00M |
| Net Income | -73.00M |
| EBITDA | -77.36M |
| EBIT | -77.39M |
| Earnings Per Share (EPS) | -1.07 |
Balance Sheet
The company has 120.17 million in cash and 2.02 million in debt, with a net cash position of 118.16 million or 1.54 per share.
| Cash & Cash Equivalents | 120.17M |
| Total Debt | 2.02M |
| Net Cash | 118.16M |
| Net Cash Per Share | 1.54 |
| Equity (Book Value) | 114.46M |
| Book Value Per Share | 1.68 |
| Working Capital | 113.55M |
Cash Flow
| Operating Cash Flow | -75.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 29,250 |
| Net Borrowing | -926,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSL:LYTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |